Oncostellae

Biotech startup

Startup

ABOUT ONCOSTELLAE

      
Oncostellae is a biotech startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
The company was founded in 2013 by a team of medicinal chemists and pharmacologists with a common track record in drug discovery who bring together the experience and network of collaborators to develop clinical candidates from their conception until Phase I/II. Further development and commercialization rights will be licensed to consolidated pharmaceutical companies. 
In 2014 Guido Kurz, a seasoned research manager with international trajectory in various pharmaceutical and biotech companies (including Pharmacia Corp. and Oryzon Genomics), joined Oncostellae as CEO of the company.
    
Organization founded in Spain.

SECTORS - INDUSTRY

LOCATIONS

PROFILE STRENGTH

This profile looks great, do you want to share it with the world?
BEGINNER
ADVANCED
REAL PRO

NEWS

Recently added news from Oncostellae:
Oncostellae cierra una ronda de 1,8 millones de euros

This website uses cookies to allow us to see how the site is used. If you continue to use this site we will assume that you are happy with this. If you want to use the site without cookies or would like to know more, you can do that. here .